BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36280238)

  • 21. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
    Britsemmer K; van Schaardenburg D; Boers M; De Cock D; Verschueren P; Radner H; Smolen JS; van Tuyl LHD
    Clin Exp Rheumatol; 2018; 36(3):362-370. PubMed ID: 29533752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis.
    Carvalho PD; Ferreira RJO; Landewé R; Vega-Morales D; Salomon-Escoto K; Veale DJ; Chopra A; da Silva JAP; Machado PM
    J Rheumatol; 2020 Jan; 47(1):20-27. PubMed ID: 31043552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.
    Wang GY; Zhang SL; Wang XR; Feng M; Li C; An Y; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Yan HM; Wang GC; Lu X; Liu X; Zhu P; Chen LN; Jin HT; Liu JT; Guo HF; Chen HY; Xie JL; Wei P; Wang JX; Liu XY; Sun L; Cui LF; Shu R; Liu BL; Yu P; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Han SL; Yang XY; Li H; Huang CB; Gao M; Lai B; Cheng YJ; Li XF; Song LJ; Yu XX; Wang AX; Wu LJ; Wang YH; He L; Sun WW; Gong L; Wang XY; Wang Y; Zhao Y; Li XX; Wang Y; Zhang Y; Su Y; Zhang CF; Mu R; Li ZG
    Clin Rheumatol; 2015 Feb; 34(2):221-30. PubMed ID: 25413735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Celis R; Ruiz-Esquide V; Castellanos-Moreira R; Ponce A; Gómez-Puerta JA; Sanmartí R; Cañete JD
    Clin Rheumatol; 2021 Jul; 40(7):2665-2672. PubMed ID: 33506371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
    van Gestel AM; Anderson JJ; van Riel PL; Boers M; Haagsma CJ; Rich B; Wells G; Lange ML; Felson DT
    J Rheumatol; 1999 Mar; 26(3):705-11. PubMed ID: 10090187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
    Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?
    Duarte C; Ferreira RJO; Welsing PMJ; Jacobs JWG; Gossec L; Machado PM; van der Heijde D; da Silva JAP
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38443090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients.
    Ferreira RJO; Welsing PMJ; Jacobs JWG; Gossec L; Ndosi M; Machado PM; van der Heijde D; Da Silva JAP
    Ann Rheum Dis; 2021 Mar; 80(3):293-303. PubMed ID: 33023964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
    Inanc N; Yilmaz-Oner S; Can M; Sokka T; Direskeneli H
    J Rheumatol; 2014 Sep; 41(9):1755-60. PubMed ID: 25086073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index.
    Aletaha D; Martinez-Avila J; Kvien TK; Smolen JS
    Ann Rheum Dis; 2012 Jul; 71(7):1190-6. PubMed ID: 22454398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of ACR/EULAR definition of remission in rheumatoid arthritis from RA practice: the ESPOIR cohort.
    Zhang B; Combe B; Rincheval N; Felson DT
    Arthritis Res Ther; 2012 Jun; 14(3):R156. PubMed ID: 22747951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study.
    Paulshus Sundlisæter N; Sundin U; Aga AB; Sexton J; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Lillegraven S
    RMD Open; 2022 Jan; 8(1):. PubMed ID: 35091463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M; ;
    Arthritis Rheum; 2011 Mar; 63(3):573-86. PubMed ID: 21294106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.